Results 191 to 200 of about 2,570,930 (351)

Anaesthesia for renal transplant surgery: an update

open access: yesEuropean Journal of Anaesthesiology, 2012
S. Schmid, B. Jungwirth
semanticscholar   +1 more source

“Intrapericardial Approach” for Venous Outflow Reconstruction in Living‐Donor Liver Transplantation for Budd‐Chiari Syndrome: Surgical Techniques and LongTerm Outcomes

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata   +4 more
wiley   +1 more source

Terminal Complement Inhibition Decreases Antibody‐Mediated Rejection in Sensitized Renal Transplant Recipients

open access: yesAmerican Journal of Transplantation, 2011
M. Stegall   +10 more
semanticscholar   +1 more source

Congophilic fibrillary glomerulonephritis recurrence post-renal transplant: diagnostic challenges and proteomic insights. [PDF]

open access: yesCEN Case Rep
Watanabe H   +7 more
europepmc   +1 more source

Clinical role of the renal transplant biopsy

open access: yesNature Reviews Nephrology, 2012
W. Williams   +3 more
semanticscholar   +1 more source

The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia‐Associated Kidney Function

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Progressive kidney injury is a major cause of morbidity and mortality in sickle cell anemia (SCA). The high risk APOL1 G1/G2 variants contribute to the development of kidney disease in individuals of African ancestry, including those with SCA.
Sara R. Rashkin   +7 more
wiley   +1 more source

Renal and Cardiovascular Outcomes in Renal Transplant Candidates According to Coronary Status. [PDF]

open access: yesJ Am Heart Assoc
Giovachini L   +16 more
europepmc   +1 more source

FK506 IN CLINICAL ORGAN-TRANSPLANTATION [PDF]

open access: yes, 1991
ABUELMAGD, K   +14 more
core  

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo   +38 more
wiley   +1 more source

Home - About - Disclaimer - Privacy